top of page
Kv9 logo

Improving the lives of dogs with cancer

Black and white dog with big eyes

Why do we care?

Sad dog getting treatment at veterinary clinic
Cancer is the leading cause of death in dogs

Approximately ~6 million dogs in the US get cancer per year and ~30 million dogs get cancer per year globally

There is a lack of treatments that are safe, easy, accessible and affordable

Up to 60% of pets owners decline treatment due to concerns about cost, quality of life and side effects of treatment. 

​

 

And 94% of pets with cancer never visit a specialist due to costs, access to specialist clinics and time commitment.

Yet up to 70% of treatment options require a specialist.

Kv9 is designed to create a personalised treatment by labelling cancer cells in-situ and activating the patient’s immune system

Image depicting Kv9 treatment sequence. Inject Kv9 into tumour, label detection, immune response, tumour detection.

 

Kv9 is modelled off AGI-134, an experimental human cancer immunotherapy.

We utilise the same technology but use an animal appropriate antigen to activate the immune system. 

Kv9 is currently undergoing clinical trials 
Find out more here 

bottom of page